24 September 2015 - Top U.S. heart doctors said on Thursday that newly developed cholesterol treatments that cost more than $14,000 per year are best used for the small group of patients for which they have been approved, at least for now.

The drugs are vastly more expensive than the statins that are currently used by tens of millions of people to help control high cholesterol and have drawn scrutiny from health insurers who are concerned they will be widely prescribed.

The physicians' views, detailed during a Rethinking Cholesterol panel presented by Harvard T.H. Chan School of Public Health in collaboration with Reuters, is not much different than that of some health insurers.

For more details, go to: http://www.reuters.com/article/2015/09/24/us-usa-healthcare-cholesterol-idUSKCN0RO2DD20150924